The Taubman Institute has appointed a physician-researcher studying macular degeneration as the latest member of its Emerging Scholars Program. Thomas J. Wubben, MD, PhD, is an assistant professor at Michigan Medicine’s Kellogg Eye Center, where he cares for patients with diseases of the retina. Dr. Wubben is a translational-research ophthalmologist whose clinical specialization is in…
Michigan Medicine’s October 3 cardiovascular symposium will include two Taubman Scholars among other featured speakers. The symposium, which focuses on the biology of cardiovascular aging and is dubbed M-BOCA, is named for Daniel R. Goldstein, MD, co-leader of one of the first Taubman Institute Innovation Projects. Known as ImPrec, the project aims to personalize anti-rejection…
A Michigan Medicine urologist seeking to improve early detection of prostate and kidney cancer is the newest Taubman Emerging Scholar. Simpa Salami, MD, MPH, has been named the Brian and Rosaline Chamberlain Emerging Scholar, and will receive a five-year financial grant as well as mentorship and other support from the Taubman Institute community. Dr. Salami’s…
The founding director of the Taubman Institute, Eva L. Feldman, MD, PhD, has been honored with a professorship in her name, established by longtime institute benefactor Edith Briskin. Dr. Feldman, the James W. Albers Distinguished University Professor and Russell N. DeJong Professor of Neurology, is known internationally for her groundbreaking research and leadership across neurological…
